Wyeth

Croda, Inc.

Equus UK Topco Ltd

Cargill Bioindustrial UK Limited

Zhongqi Shen

Xin Chen

Boyd Lynn Harrison

Wayne Everett Childers

Annmarie Louise Sabb

Magda Asselin

Craig M Sungail

George Theodore Grosu

Lisa Marie Havran

Min Ma Wang

Alexei Nikolaevich Kurchan

P Sivaramakrishnan Ramamoorthy

James Jacob Bicksler

Dan Chaekoo Chong

Craig Michael Sungail

A lubricating composition comprises an amide and at least one additive. The amide is the reaction product of a secondary, branched amine and a carboxylic acid. The carboxylic acid may be a monocarboxylic acid or a dicarboxylic acid, including dimer acid. The amide is hydrolytically stable, and may be used to increase the hydrolytic stability of the lubricant composition. Alternatively, the amide may be used to increase the additive solubility or detergency of the lubricant composition.

Lubricating oils

Provided is a method of dispersing asphaltenes to inhibit asphaltene precipitation and/or deposition in a hydrocarbon. The method includes adding to the hydrocarbon an asphaltene dispersing agent which is an ester of a mono-carboxylic fatty acid and a sugar. The sugar has at least 4 hydroxyl groups. In addition, more than one of the hydroxyl groups on the sugar are reacted with the mono-carboxylic fatty acid to form the ester.

Method and composition for asphaltene dispersion

The present invention relates to novel piperazine-piperidine compounds. The compounds are useful as 5-HT1A binding agents, particularly as 5-HT1A receptor antagonists and agonists. These compounds are useful in treating central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction. The invention relates to compounds and pharmaceutically acceptable salts of formula (I'): wherein R-R, R, R, and n are set forth in the specification. The invention also relates to pharmaceutical compositions comprising compounds and pharmaceutically acceptable salts of formula (I&#x2032;).

[object Object]

3-Amino chroman and 2-amino tetralin derivatives and compositions containing such compounds are disclosed. Such compounds are useful for modulating activity of a 5-HTreceptor (agonizing or antagonizing) in a patient. These compounds are further useful for inhibiting binding to a serotonin receptor. Methods of using the 3-amino chroman and 2-amino tetralin compounds and compositions containing such compounds in the treatment of serotonin disorders, such as depression and anxiety, are also disclosed.

Growing community of inventors

Plainsboro, NJ, United States of America

Zhongqi Shen